MicuRx Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- MicuRx Pharmaceuticals's estimated annual revenue is currently $2.2M per year.
- MicuRx Pharmaceuticals's estimated revenue per employee is $77,500
- MicuRx Pharmaceuticals's total funding is $161.3M.
Employee Data
- MicuRx Pharmaceuticals has 29 Employees.
- MicuRx Pharmaceuticals grew their employee count by 7% last year.
MicuRx Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER | Reveal Email/Phone |
2 | Head Chemistry/Senior Director/Director/Senior Scientist | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Unblinded Global Project Manager | Reveal Email/Phone |
8 | President/CEO | Reveal Email/Phone |
9 | Senior Director Business Development | Reveal Email/Phone |
10 | Financial Controller | Reveal Email/Phone |
MicuRx Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is MicuRx Pharmaceuticals?
MicuRx undertakes a highly efficient "de-risked" approach to expediently build a strong pipeline of pre-clinical and clinical products by focusing its innovative research on existing classes of under-explored but validated anti-infective structures. Based on advanced analysis of medical needs and identification of new scientific approaches to design superior pharmaceuticals, MicuRx team applies its unique expertise and creativity towards an expedient delivery of best-in-class agents with a blockbuster potential. With initial focus on antifungal and antibacterial chemotypes, this revolutionary strategy seeks to deliver IND candidates in a record short time.
keywords:N/A
$161.3M
Total Funding
29
Number of Employees
$2.2M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MicuRx Pharmaceuticals News
Know more about which pharma player in the Common Warts market is set ... MicuRx Pharmaceuticals, TenNor Therapeutics Limited, among others.
MicuRx Pharmaceuticals, Inc., an Hayward, CA- and Shangai-based biopharmaceutical company, China-based closed a ¥100m financing. The round was led by existing investors Delian Capital and BVCF. The company intends to use the funds for the completion of the ongoing Phase 3 program for its oral ...
MicuRx Pharmaceuticals, Inc., a Hayward, Calif. and Shangai, China-based developer of next-generation antibiotic, closed a $55m Series C financing. The round was led by GP Healthcare Capital with participation from new investors GP TMT Capital, 3E Bioventures Capital, and Delian Capital. In con ...
MicuRx Pharmaceuticals, Inc., a Hayward, CA-based biopharmaceutical company developing innovative antibiotics, raised $25m in Series B financing. The round was led by BVCF, with participation from existing investors Morningside Group and Devon Park Bioventures. In conjunction with the funding, ...
Other Companies in Hayward
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.2M | 29 | 16% | N/A |
#2 | $2.1M | 29 | 38% | $31.9M |
#3 | $5.5M | 29 | 7% | N/A |
#4 | N/A | 30 | 7% | N/A |
#5 | $4.9M | 30 | 0% | N/A |